R. Paul Fonteyne - Insider Trading & Ownership

Entity
Individual
Location
C/O Restorbio, Inc., 501 Boylston Street Suite 6102, Boston, MA
Summary
The estimated net worth of R. Paul Fonteyne is at least $696K dollars as of January 3, 2025. R. Paul Fonteyne is the Director of Apellis Pharmaceuticals, Inc. and owns shares of Apellis Pharmaceuticals, Inc. (APLS) stock worth about $696K.
All Insider Reports
All Insider Reports

Ownership of R. Paul Fonteyne

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
APLS Apellis Pharmaceuticals, Inc. Director $696K Jan 1, 2025
AMLX Amylyx Pharmaceuticals, Inc. Director Jun 6, 2024
CVET COVETRUS, INC. Director Oct 13, 2022
GLSHQ GELESIS HOLDINGS, INC. Director May 6, 2022

Insider Transactions Reported by R. Paul Fonteyne:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.